Peripheral Vascular Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Peripheral Vascular Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

The global peripheral vascular devices market size reached US$ 10.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 16.0 Billion by 2028, exhibiting a growth rate (CAGR) of 6.8% during 2023-2028.

Peripheral vascular disease (PVD) is a circulatory condition caused due to the narrowing, blockage, or spasms in the blood vessels located outside the heart and brain. Such occurrences reduce the blood flow through the vessels, resulting in weakness, pain, gangrene, hair loss on the legs, numbness, and muscle heaviness. Peripheral vascular devices, such as angioplasty catheters, peripheral guidewires, vena cava filters, stent grafts, and embolic protection devices (EPD), are used to treat artery blockages and narrowing. These blockages, particularly found in the peripheral vasculature, are caused by plaque build-up, which limits the blood vessels and reduces blood flow to the body parts. Peripheral vascular devices are safe, minimize the risk of infection and irritation, improve blood flow, and supply oxygenated blood through arteries.

Peripheral Vascular Devices Market Trends:
The increasing prevalence of venous diseases or CVI (chronic venous insufficiency) across the globe is creating a positive outlook for the market. Peripheral vascular devices provide sufficient blood flow to the brain, legs, and feet for proper functioning. Additionally, the rising geriatric population and the increasing incidences of various ailments, such as peripheral artery disease (PAD) and blockages, are favoring the market growth. Furthermore, this can be attributed to changing lifestyle habits, including smoking and high alcohol consumption, coupled with physical inactivity and unhealthy dietary habits. Apart from this, the growing inclination toward minimally invasive surgeries (MIS) due to fewer complications, less postoperative pain, shortened hospital stay, and faster recovery times are providing an impetus to the market growth. Moreover, the widespread adoption of atherectomy devices owing to the increasing prevalence of atherosclerosis, obesity, and lifestyle-related disorders is positively influencing the market growth. Other factors, including the significant growth in the healthcare industry, rising expenditure capacities of consumers, and extensive research and development (R&D) activities, are anticipated to drive the market toward growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global peripheral vascular devices market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on device type and end user.

Breakup by Device Type:

Peripheral Vascular Stents
Peripheral Transluminal Angioplasty (PTA) Balloon Catheters
Peripheral Transluminal Angioplasty (PTA) Guidewires
Atherectomy Devices
Embolic Protection Devices
Inferior Vena Cava Filters
Others

Breakup by End User:

Hospitals and Clinics
Ambulatory Care Centers
Specialty Clinics
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, B. Braun SE (B. Braun Holding GmbH & Co. KG), Becton, Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corporation, Cook Group Incorporated, Cordis Corporation, iVascular S.L.U., Koninklijke Philips N.V., Medtronic plc and Terumo Medical Corporation.

Key Questions Answered in This Report

1. What was the size of the global peripheral vascular devices market in 2022?
2. What is the expected growth rate of the global peripheral vascular devices market during 2023-2028?
3. What are the key factors driving the global peripheral vascular devices market?
4. What has been the impact of COVID-19 on the global peripheral vascular devices market?
5. What is the breakup of the global peripheral vascular devices market based on the device type?
6. What is the breakup of the global peripheral vascular devices market based on the end user?
7. What are the key regions in the global peripheral vascular devices market?
8. Who are the key players/companies in the global peripheral vascular devices market?


1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Peripheral Vascular Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Device Type
6.1 Peripheral Vascular Stents
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Peripheral Transluminal Angioplasty (PTA) Balloon Catheters
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Peripheral Transluminal Angioplasty (PTA) Guidewires
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Atherectomy Devices
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Embolic Protection Devices
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Inferior Vena Cava Filters
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Others
6.7.1 Market Trends
6.7.2 Market Forecast
7 Market Breakup by End User
7.1 Hospitals and Clinics
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Ambulatory Care Centers
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Specialty Clinics
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Abbott Laboratories
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 B. Braun SE (B. Braun Holding GmbH & Co. KG)
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 SWOT Analysis
13.3.3 Becton, Dickinson and Company
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.3.4 SWOT Analysis
13.3.4 Biotronik SE & Co. KG
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 SWOT Analysis
13.3.5 Boston Scientific Corporation
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.5.4 SWOT Analysis
13.3.6 Cook Group Incorporated
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.7 Cordis Corporation
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.8 iVascular S.L.U.
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.9 Koninklijke Philips N.V.
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
13.3.10 Medtronic plc
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 Financials
13.3.10.4 SWOT Analysis
13.3.11 Terumo Medical Corporation
13.3.11.1 Company Overview
13.3.11.2 Product Portfolio
13.3.11.3 Financials
13.3.11.4 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings